Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17
Closed -$252 5059
2025
Q4
$252 Hold
17
﹤0.01% 4438
2025
Q3
$250 Buy
+17
New +$173 ﹤0.01% 4353
2025
Q2
Hold
0
3618
2025
Q1
Hold
0
3922
2024
Q4
Hold
0
4084

IFP Advisors's ETNB Position: Q1 2026 in Review

IFP Advisors sold out of 89bio (ETNB) in Q1 2026, closing a stake of 17 shares — an estimated $252 sold.

IFP Advisors first reported a position in ETNB in Q3 2025 and held it in 2 quarters. The position peaked at $252 in Q4 2025. 0 funds tracked by Wall St. Rank hold ETNB as of Q1 2026.

  • IFP Advisors reported no remaining 89bio position as of Q1 2026 after selling out during the quarter.
  • IFP Advisors sold 17 89bio shares in Q1 2026, an estimated $252.
  • IFP Advisors first reported a position in 89bio in Q3 2025 and held it in 2 quarters.
  • IFP Advisors's 89bio position peaked at $252 in Q4 2025.
  • 0 funds tracked by Wall St. Rank held 89bio as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.